Warner Pharmaceutical: Obtained registration certificate for metformin and empagliflozin tablets.

Warner Pharmaceutical Factory announced that the company has recently received the Drug Registration Certificate for Metformin and Linagliptin Tablets issued by the National Medical Products Administration. This drug is classified as a Category 4 chemical drug and is considered equivalent through consistency evaluation. It is suitable for type 2 diabetes adult patients who are currently receiving treatment with Linagliptin and Metformin Hydrochloride. The company stated that the approval of this product will further enrich the variety of formulations and optimize the product structure, but it will not have a significant impact on the company's recent performance. The future sales will be affected by multiple factors such as policies, markets, and competition, leading to uncertainties.